Transcriptomic Analysis Implicates Necroptosis in Disease Progression and Prognosis in Myelodysplastic Syndromes

Authors

Guillermo Montalban-Bravo, University of Texas MD Anderson Cancer Center
Caleb Class, University of Texas MD Anderson Cancer Center
Irene Ganan-Gomez, University of Texas MD Anderson Cancer Center
Rashmi Kanagal-Shamanna, University of Texas MD Anderson Cancer Center
Koji Sasaki, University of Texas MD Anderson Cancer Center
Guillaume Richard-Carpentier, University of Texas MD Anderson Cancer Center
Kiran Naqvi, University of Texas MD Anderson Cancer Center
Yue Wei, University of Texas MD Anderson Cancer Center
Hui Yang, University of Texas MD Anderson Cancer Center
Kelly Soltysiak, University of Texas MD Anderson Cancer Center
Kelly Chien, University of Texas MD Anderson Cancer Center
Carlos Bueso-Ramos, University of Texas MD Anderson Cancer Center
Kim-Anh Do, University of Texas MD Anderson Cancer Center
Hagop Kantarjian, University of Texas MD Anderson Cancer Center
Guillermo Garcia-Manero, University of Texas MD Anderson Cancer Center

Document Type

Article

Publication Date

November 2019

Publication Title

Blood

First Page

3006

Last Page

3006

DOI

10.1182/BLOOD-2019-124957

Recommended Citation

Montalban-Bravo, Guillermo; Class, Caleb; Ganan-Gomez, Irene; Kanagal-Shamanna, Rashmi; Sasaki, Koji; Richard-Carpentier, Guillaume; Naqvi, Kiran; Wei, Yue; Yang, Hui; Soltysiak, Kelly; Chien, Kelly; Bueso-Ramos, Carlos; Do, Kim-Anh; Kantarjian, Hagop; and Garcia-Manero, Guillermo, "Transcriptomic Analysis Implicates Necroptosis in Disease Progression and Prognosis in Myelodysplastic Syndromes" (2019). Scholarship and Professional Work – COPHS. 279.
https://digitalcommons.butler.edu/cophs_papers/279